Đang chuẩn bị liên kết để tải về tài liệu:
An evaluation in vitro of PARP-1 inhibitors, rucaparib and olaparib, as radiosensitisers for the treatment of neuroblastoma

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

The radiopharmaceutical 131I-meta-iodobenzylguanidine (131I-MIBG) is an effective treatment for neuroblastoma. However, maximal therapeutic benefit from 131I-MIBG is likely to be obtained by its combination with chemotherapy. We previously reported enhanced antitumour efficacy of 131I-MIBG by inhibition of the poly(ADP-ribose) polymerase-1 (PARP-1) DNA repair pathway using the phenanthridinone derivative PJ34. |

TÀI LIỆU LIÊN QUAN

In vitro evaluation of various fungicides and plant extracts against Xanthomonas oryazae Pv. oryzae isolated from rice (Oryza sativa L.)

In-vitro evaluation of different fungicides and bioagents against Fusarium oxysporum f. sp. lycopersici

In vitro evaluation of rice genotypes for brown plant hopper (Nilaparvata lugens Stal.) resistance

In vitro evaluation for antagonistic potential of some bio control isolates against important foliar fungal pathogens of cowpea

In vitro nutritional evaluation of concentrates containing different levels of duckweed supplementation as protein source for ruminants

In vitro nutritional evaluation and digestion kinetics of concentrates containing varying levels of Moringa oleifera leaf meal supplementation as protein source for goats

In-vitro effect evaluation of botanicals against Sclerotinia sclerotiorum (Lib.) De Bary, caused stem rot disease in rapeseed-mustard

Synthesis, in vitro acetylcholinesterase inhibitory activity evaluation and docking investigation of some aromatic chalcones

Evaluation of fungicides in vitro against Alternaria porri causing purple blotch of onion

In vitro evaluation of fungicides, botanicles and bio-agents against alternaria alternata causal agent of fruit rot of Brinjal